EVEXIAS Health Solutions

What EVEXIAS Health Solutions does

EVEXIAS Health Solutions is a Texas-based, founder-led integrative medicine company founded in 2018 that develops and distributes a proprietary bioidentical hormone pellet therapy called the EvexiPEL Method, supported by a portfolio of 55+ pharmaceutical-grade nutraceuticals and peptide therapy services. The company's core technology is the EvexiPEL method, which combines a patented pellet delivery system for bioidentical hormone replacement with patented nutraceutical formulas and standardized clinical protocols for hormone optimization in men and women. Products span 18+ therapeutic categories including hormone balance, thyroid, GI health, detoxification, brain/cognition, inflammation, immune health, metabolism, and women's and men's health, with multiple SKUs launched or relaunched through 2025-2026.

The business operates as a B2B2C platform via an exclusive certified-provider network: healthcare practitioners (physicians, nurse practitioners, and other licensed providers) complete EvexiPEL training and certification, then deliver hormone optimization therapy, peptide therapy, and proprietary nutraceuticals to patients through their own practices. Revenue is generated from three primary streams: (1) provider training, certification, and ongoing education; (2) sale of proprietary nutraceuticals to certified providers; and (3) the therapy-delivery ecosystem that flows through provider networks serving patients nationwide. The company is led by founders Dr. Terri DeNeui (DNP, APRN, ACNP-BC) and Dan DeNeui (CEO), with Lisa Mikals as Chief Operating Officer, and operates from a single headquarters in Southlake, Texas serving the US market exclusively.

Name

EVEXIAS Health Solutions

Legal name

EVEXIAS Health Solutions LLC

Website

https://evexias.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

EVEXIAS Health Solutions is a Texas-based integrative medicine company that distributes proprietary bioidentical hormone pellet therapy (EvexiPEL Method) and 55+ pharmaceutical-grade nutraceuticals through a nationwide network of certified healthcare providers.

Ownership category

akta.pro rank

Headquarters

HQ city

Southlake

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Supply Chain

Revenue model

1. EvexiPEL Hormone Therapy: Revenue generated from training and certifying healthcare providers in the EvexiPEL Method. Providers then deliver hormone optimization therapies including pellet therapy, peptide therapy, and prescribe nutraceuticals to patients. The company generates revenue through the provider network model.
2. Nutraceutical Products: Sale of proprietary pharmaceutical-grade nutraceutical supplements through the provider network. Products are available only through EvexiPEL providers as part of personalized care protocols.
3. Provider Training & Certification: Revenue from training healthcare practitioners in EvexiPEL methodology, protocol development and support, and ongoing education programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

EVEXIAS Health Solutions operates a healthcare services and products platform built around EvexiPEL, its proprietary bioidentical hormone pellet therapy method. The company trains and certifies a national network of licensed healthcare practitioners who deliver EvexiPEL hormone optimization, peptide therapy, and a 55+ product line of pharmaceutical-grade nutraceutical supplements to patients. EVEXIAS generates revenue by certifying providers, supplying them with proprietary protocols and nutraceuticals, and supporting their practices through ongoing education and business development resources.

Product overview

EVEXIAS Health Solutions offers a comprehensive health optimization platform centered on EvexiPEL, a proprietary bioidentical hormone pellet therapy method, complemented by an extensive portfolio of 55+ pharmaceutical-grade nutraceuticals. The company's offerings include hormone testing, peptide therapy, and hormone optimization protocols for both men and women. The EvexiPEL flagship product provides personalized pellet hormone therapy delivered through a nationwide network of trained providers, while the nutraceutical line includes targeted supplements organized into categories such as anti-aging, bone health, cardiovascular health, brain/cognition, energy support, detoxification, GI health, hormone balance, inflammation, immune health, metabolism/weight support, stress/mood/sleep, thyroid, men's health, and women's health. The company also provides practice development solutions and provider training programs.

Differentiator

Problem solved

Functional benefit

Brands

• EvexiPEL: A proprietary method of hormone pellet therapy and hormone optimization, serving as the company's flagship product and training methodology.
• EvexiTHROID
• EvexiGLPRO

Products and services

• EvexiPEL Bioidentical Hormone Pellet Therapy
• Peptide Therapy
• Hormone Testing and Hormone Imbalance Treatment Services
• EvexiPEL Provider Training and Certification Program
• Practice and Provider Solutions
• EVEXIAS Nutraceutical Line (55+ Pharmaceutical-Grade Supplements)

Quantifiable outcome

• Thousands of EvexiPEL Certified Providers nationwide with new markets opening each month
• +1 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Biote Medical: Direct competitor in bioidentical hormone pellet therapy. Biote is the most comparable peer to EVEXIAS's EvexiPEL, sharing the BHRT pellet model and certified-provider network. EVEXIAS and Biote were also litigation adversaries, underscoring their direct competition.
• SottoPelle: Direct peer in bioidentical hormone pellet therapy, offering subcutaneous hormone pellets through a provider network. Operates a similar practitioner-network model for BHRT delivery, comparable to EvexiPEL.
• BodyLogicMD: Network of integrative medicine physicians specializing in bioidentical hormone replacement therapy, hormone optimization, and wellness. Closely comparable to EVEXIAS in combining a provider-network delivery model with hormone therapy and supplements.
• Defy Medical: Hormone replacement therapy and wellness clinic offering BHRT, testosterone therapy, and peptide therapy. Comparable to EVEXIAS in the practitioner-delivered hormone optimization category.
• Hormone Therapeutics: Hormone replacement therapy provider offering BHRT, testosterone, and related services to patients. Comparable to EVEXIAS in the practitioner-delivered hormone optimization space.

Emerging players

• Marek Health: Direct-to-consumer men's hormone optimization and TRT platform. Overlaps with EVEXIAS's male hormone therapy segment but reaches patients via telehealth rather than a certified-provider network.
• Winona: Telehealth platform for menopausal hormone therapy, addressing women's midlife hormone health. Comparable patient segment to EVEXIAS women, but delivered virtually rather than through a certified-provider network.
• Midi Health: Virtual clinic for midlife women's health, including hormone therapy, perimenopause, and menopause care. Comparable patient population to EVEXIAS, but a different telehealth-first delivery model.
• Evernow: Women's hormonal health platform focused on menopause and perimenopause, with telehealth-based hormone therapy. Similar patient population to EVEXIAS, narrower indication set, and digital-first delivery.
• AgelessRx: Telehealth longevity clinic offering hormone optimization, peptides, and anti-aging therapies. Comparable to EVEXIAS in the hormone + peptide service line, but direct-to-consumer virtual rather than provider-network based.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/EVEXIASHealthSolutions
• LinkedInlinkedin.com/company/evexiashealthsolutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EVEXIAS Health Solutions